Targeted Mutations Identify the Active Site of
Glucocorticoid-Induced Leucine Zipper (GILZ)
Dr Hua
Peng Fan, Research
Fellow
Monash
University Centre for Inflammatory Diseases
Currently I am a Post-doc research fellow in Lupus and
Arthritis Research Group, Monash Medical Centre, doing research in human
inflammatory and autoimmune diseases including RA and SLE. My project focuses
on the mechanism study of pro-inflammatory cytokine MIF and GILZ, a
glucocorticoid-induced molecule. In my previous study, I proved the role of MIF
in leukocyte recruitment in inflammatory disease. For the first time, I also
identified that GILZ is indeed a novel target of MIF. The finding that GILZ
mediates the antagonistic effect of MIF on glucocorticoid actions suggests its
potential as a therapeutic target of inflammatory diseases. My current project
focuses on the study of GILZ acetylation and its role in regulation of GILZ
anti-inflammatory functions.
The IL-7Ra on CD8+ cell: a potential
therapeutic target in ANCA-associated glomerulonephritis
Dr
Maliha Alikhan
Research
Fellow
Monash
University Centre for Inflammatory Diseases
Maliha Alikhan is a Research Fellow in the Centre for
Inflammatory Diseases. Maliha completed her PhD at Monash University in 2012,
investigating the role of macrophages in acute kidney injury under the
supervision of Professor Sharon Ricardo. She joined the group of Professor
Richard Kitching in 2013 and has since been researching the innate and adaptive
immune responses in experimental models of acute kidney injury and autoimmune
anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis.
Maliha is currently focusing on the role of memory CD8 T cells in
ANCA-associated glomerulonephritis and working to characterise a new potential
and targeted treatment option.
Further information available from CID Weekly Seminar Series website [http://www.med.monash.edu.au/scs/medicine/cid/seminar-series.html]
The CiiiD Tuesday Meeting is
held directly after at 1:00pm. Nicole de Weerd will be presenting on
Tuesday 4 October.
No comments:
Post a Comment